• Advertise
  • About us
  • Terms and Conditions
  • Contact us
Thursday, July 17, 2025
Australian Times News
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia
No Result
View All Result
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia
No Result
View All Result
Australian Times News
No Result
View All Result
Home News

Australia secures access to additional Covid-19 medical treatment

Government has made a deal to buy 300,000 courses of Molnupiravir, a new oral Covid treatment for people with milder symptoms.

Mike Simpson by Mike Simpson
05-10-2021 14:57
in News
Scott Morrison. Photo credit: Kristy Robinson / Commonwealth of Australia, via Wikipedia

Scott Morrison. Photo credit: Kristy Robinson / Commonwealth of Australia, via Wikipedia

Australia will have access to an additional Covid-19 treatment following the Morrison Government’s deal to purchase 300,000 courses of the promising oral Covid treatment, Molnupiravir.

Molnupiravir is an oral antiviral that is being developed for the first-line treatment of Covid-19 in adult patients with mild-to-moderate symptoms.

According to the Federal Government, treatment with the oral antiviral has been shown to stop people with Covid developing serious symptoms, keeping them out of hospital and preventing serious illness and death.

Whilst Molnupiravir is in late-stage clinical trials, the agreement between Merck Sharp & Dohme is for supply to Australia, should it be approved by the Therapeutic Good Administration (TGA), during early 2022.

Must have access to promising treatments

Prime Minister Scott Morrison said the Government was ensuring Australians had access not only to Covid-19 vaccines, but also promising treatments.

“Vaccines and new treatments like this will boost our National Plan to safely reopen Australia and keep Australia safely open,” the Prime Minister said.

“Throughout this pandemic we’ve been closely watching developments for Covid vaccines and treatments, and Molnupiravir will be ready to go in Australia, should it be approved by the TGA.

“While our vaccination rate continues to climb, we’ve been investing in and closely monitoring research into treatments, and we are securing supply of promising treatments.

AlsoRead...

The Broker who says ‘Yes’ when Banks say NO

The Broker who says ‘Yes’ when Banks say NO

8 July 2025
Leading with Trust: Why Quality still wins in the AI Era

Leading with Trust: Why Quality still wins in the AI Era

5 June 2025

“If the medical experts at the TGA approve this treatment for use, it will join other Covid-19 treatments such as Sotrovimab and Remdesivir, which are already available to Australian doctors to help treat those with Covid-19.”

Capsule is ideal for use in the rural areas

Molnupiravir is a capsule that is taken twice a day for five days by adult patients with mild-to-moderate symptoms and does not need to be refrigerated, allowing it to be used in the community or as a targeted intervention at high-risk locations and in rural areas.

The makers of Molnupiravir, MSD and Ridgeback Biotherapeutics, have recently announced that Molnupiravir reduced the risk of hospitalisation or death from Covid by 50 percent at a planned interim analysis of the Phase Three trial.

Minister for Health and Aged Care, Greg Hunt, noted that these positive results added to the ongoing analysis the TGA has been undertaking into Molnupiravir.

“All Covid-19 treatment assessment processes are being treated with the greatest priority as part of the Government’s response to the pandemic,” Hunt said.

Tags: AustraliaCovid-19 in AustraliaCovid-19 treatmentMedical researchScott Morrison
DMCA.com Protection Status

SUBSCRIBE to our NEWSLETTER

[mc4wp_form id=”2384248″]

Don't Miss

The Dating Wealth Gap Is Getting Wider: What You Should Know

by Fazila Olla-Logday
11 July 2025
Source: Pixabay
Lifestyle

The divide between wealth and romance is growing. As income inequality widens, financial status is playing a bigger role in...

Read more

The Broker who says ‘Yes’ when Banks say NO

by Pauline Torongo
8 July 2025
The Broker who says ‘Yes’ when Banks say NO
Business & Finance

When faced with constant loan rejection or last-minute withdrawals of support, Trelos Finance stands out as a solution.

Read more

Common Mistakes When Buying a Telescope — And How to Avoid Them

by Fazila Olla-Logday
1 July 2025
Common Mistakes When Buying a Telescope
Technology

You’ve spent hours scrolling through telescope specs online, dazzled by features and grand promises. The excitement builds—until your newly arrived...

Read more

From Portugal to Bali: Where Aussies Should Go for Your Next Coastal Holiday

by Fazila Olla-Logday
20 June 2025
Source: Flickr
Travel

Aussies, here is a guide to where you should go for your next coastal holiday.

Read more

Leading with Trust: Why Quality still wins in the AI Era

by Pauline Torongo
5 June 2025
Leading with Trust: Why Quality still wins in the AI Era
Business & Finance

If you're leading a software team today, you've likely noticed the shift: faster feature rollouts, routine automation, and AI taking...

Read more

How to Save on Airport Parking: Budget Tips Every Traveller Should Know

by Fazila Olla-Logday
3 June 2025
How to Save on Airport Parking
Travel

Saving money on airport parking can be a challenge,but here are some budget friendly tips to help you navigate.

Read more

Why Australian Investors are Betting on the Aviation Maverick Louis Belanger-Martin

by Pauline Torongo
28 May 2025
Why Australian Investors are Betting on the Aviation Maverick Louis Belanger-Martin
Business & Finance

Bélanger-Martin’s ambitions stretch beyond redefining inflight comfort—they’re rooted in resurrecting the romance of supersonic travel with a modern twist.

Read more
Load More

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status

  • About us
  • Write for Us
  • Advertise
  • Contact us
  • T&Cs, Privacy and GDPR
No Result
View All Result
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status